2008
DOI: 10.4161/cbt.7.10.6758
|View full text |Cite
|
Sign up to set email alerts
|

A step towards a new targeted nanotherapy for pancreatic cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0
1

Year Published

2016
2016
2020
2020

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 15 publications
0
1
0
1
Order By: Relevance
“…Nanoparticle albumin bound paclitaxel are designed to deliver insoluble drug to the site of tumor. Liposomal-based nanoparticles are used to encapsulate Irinotecan which increases the efficacy of drug delivery [16]. Ultrasound-responsive nanoparticles are used in ultrasound mediated drug delivery were the nanoparticles are accumulated at the site of tumor via enhanced permeability and retention (EPR) effect and release the encapsulated drug in response to ultrasound.…”
Section: Pancreatic Ductal Adenocarcinoma (Pda)mentioning
confidence: 99%
“…Nanoparticle albumin bound paclitaxel are designed to deliver insoluble drug to the site of tumor. Liposomal-based nanoparticles are used to encapsulate Irinotecan which increases the efficacy of drug delivery [16]. Ultrasound-responsive nanoparticles are used in ultrasound mediated drug delivery were the nanoparticles are accumulated at the site of tumor via enhanced permeability and retention (EPR) effect and release the encapsulated drug in response to ultrasound.…”
Section: Pancreatic Ductal Adenocarcinoma (Pda)mentioning
confidence: 99%
“…Dalam segi formulasi telah dikembangkan metode nanomedicine yang dapat menargetkan obat ke sel tumor secara spesifik (Keen, 2008). Formulasi partikel nano dapat meningkatkan ketersediaan hayati dari obat yang larut dalam air yang buruk dengan mengatasi pembubaran obat dan / atau permeabilitas.…”
unclassified